Comparison of Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone–Dexmedetomidine Combination on Postoperative Nausea, Vomiting, and Analgesics Requirement after Gynecological Laparoscopy
Bali Journal of Anesthesiology · 2022-10 · 6 (4) · 225-230
DOI: 10.4103/bjoa.bjoa_202_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bali Journal of Anesthesiology, 2022-10. Verfasst von Vinit Kumar Srivastava und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Female patients who undergo gynecological laparoscopic surgery are more likely to suffer from postoperative nausea and vomiting (PONV). The study aimed to probe and investigate the effectiveness of intraperitoneal administration of dexamethasone, dexmedetomidine, and combination in reducing the incidence of PONV and postoperative analgesic requirements in laparoscopic hysterectomies. Materials and Methods: One hundred ninety-two female patients undergoing laparoscopic hysterectomies were randomly assigned to four groups. Anesthesia was identical in each group. Patients in the group D1 received dexamethasone 8 mg, group D2 received dexmedetomidine 1 μg/kg, group D3 received dexamethasone 8 mg + dexmedetomidine 1 μg/kg combination, and group D4 received 20 mL normal saline intraperitoneally at the end of the surgery, before trocar removal. The primary outcome was the incidence of PONV experienced by the patients within 24-h postoperative period.
Results
In the first 24 h postoperatively, the incidence of PONV was significantly reduced in D1, D2, and D3 groups compared with D4 ( P = 0.001); however, there were no significant differences among the three groups. The requirement for rescue antiemetic and rescue analgesic was similar among the groups but significantly decreased compared with the control group (group D4) ( P = 0.002 and P = 0.0003, respectively).
Conclusion
Intraperitoneal administration of dexamethasone, dexmedetomidine, and a combination of dexamethasone–dexmedetomidine in laparoscopic hysterectomies significantly reduces both PONV and postoperative analgesics requirements compared with the control group.
Zitieren
APA
Srivastava, V. K., Shree, P., Agrawal, S., Pandey, A., Babbar, K., & Manju, K. (2022). Comparison of Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone–Dexmedetomidine Combination on Postoperative Nausea, Vomiting, and Analgesics Requirement after Gynecological Laparoscopy. Bali Journal of Anesthesiology, 6(4), 225-230. https://doi.org/10.4103/bjoa.bjoa_202_22
Vancouver
Srivastava VK, Shree P, Agrawal S, Pandey A, Babbar K, Manju K. Comparison of Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone–Dexmedetomidine Combination on Postoperative Nausea, Vomiting, and Analgesics Requirement after Gynecological Laparoscopy. Bali Journal of Anesthesiology. 2022;6(4):225-230. doi:10.4103/bjoa.bjoa_202_22
BibTeX
@article{Srivastava2022,
author = {Srivastava, Vinit Kumar and Shree, Pooja and Agrawal, Sanjay and Pandey, Ambikesh and Babbar, Kavita and Manju, Kumari},
title = {Comparison of Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone–Dexmedetomidine Combination on Postoperative Nausea, Vomiting, and Analgesics Requirement after Gynecological Laparoscopy},
journal = {Bali Journal of Anesthesiology},
year = {2022},
volume = {6},
number = {4},
pages = {225--230},
doi = {10.4103/bjoa.bjoa_202_22}
}
EUVIMED